A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
Clinical trial NCT06329206 · RECRUITING
Trial details
- NCT number
- NCT06329206
- Sponsor
- Suzhou Genhouse Bio Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2026-04-25
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.